{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:20:44Z","timestamp":1787844044127,"version":"build-2784847793"},"reference-count":27,"publisher":"Society of Nuclear Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2026,7,21]]},"DOI":"10.2967\/jnumed.125.271954","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:00:19Z","timestamp":1787842819000},"page":"jnumed.125.271954","source":"Crossref","is-referenced-by-count":0,"title":["Dual-Threshold Contouring for [\n                    <sup>68<\/sup>\n                    Ga]Ga-DOTATATE PET\/CT and Correlation with Overall Survival in Patients with Neuroendocrine Neoplasms"],"prefix":"10.2967","author":[{"given":"David L.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Diakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Pavlakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Sabahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy P.","family":"Willowson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Roach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale L.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"2026082708000589000_jnumed.125.271954v1.1","doi-asserted-by":"crossref","first-page":"101598","DOI":"10.1016\/j.canep.2019.101598","article-title":"Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia","volume":"63","author":"Wyld","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"2026082708000589000_jnumed.125.271954v1.2","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.165803"},{"key":"2026082708000589000_jnumed.125.271954v1.3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/RLU.0000000000002276","article-title":"68Ga PET imaging in patients with neuroendocrine tumors: a systematic review and meta-analysis","volume":"43","author":"Singh","year":"2018","journal-title":"Clin Nucl Med."},{"key":"2026082708000589000_jnumed.125.271954v1.4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.7150\/thno.18068","article-title":"Dual somatostatin receptor\/FDG PET\/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance","volume":"7","author":"Chan","year":"2017","journal-title":"Theranostics."},{"key":"2026082708000589000_jnumed.125.271954v1.5","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32833f635e"},{"key":"2026082708000589000_jnumed.125.271954v1.6","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2967\/jnumed.120.258392","article-title":"Semiautomatic tumor delineation for evaluation of 64Cu-DOTATATE PET\/CT in patients with neuroendocrine neoplasms: prognostication based on lowest lesion uptake and total tumor volume","volume":"62","author":"Carlsen","year":"2021","journal-title":"J Nucl Med."},{"key":"2026082708000589000_jnumed.125.271954v1.7","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.3390\/cancers15143581","article-title":"Prognostic Implications of PET-derived tumor volume and uptake in patients with neuroendocrine tumors","volume":"15","author":"Weber","year":"2023","journal-title":"Cancers (Basel)."},{"key":"2026082708000589000_jnumed.125.271954v1.8","doi-asserted-by":"crossref","first-page":"11s","DOI":"10.2967\/jnumed.108.057182","article-title":"Standards for PET image acquisition and quantitative data analysis","volume":"50","author":"Boellaard","year":"2009","journal-title":"J Nucl Med."},{"key":"2026082708000589000_jnumed.125.271954v1.9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13139-017-0493-6","article-title":"Current methods to define metabolic tumor volume in positron emission tomography: which one is better?","volume":"52","author":"Im","year":"2018","journal-title":"Nucl Med Mol Imaging."},{"key":"2026082708000589000_jnumed.125.271954v1.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.057307"},{"key":"2026082708000589000_jnumed.125.271954v1.11","first-page":"3031","article-title":"Normal biodistribution and tumor uptake of 68Ga DOTATATE PET\/CT in the clinical setting: normal background activity, and organ specific tumor characterization of metastatic lesions","volume":"60","author":"Anderson","year":"2019","journal-title":"Journal of Nuclear Medicine."},{"key":"2026082708000589000_jnumed.125.271954v1.12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41824-021-00116-z","article-title":"Gallium-68-somatostatin receptor PET\/CT parameters as potential prognosticators for clinical time to progression after peptide receptor radionuclide therapy: a cohort study","volume":"5","author":"Ebbers","year":"2021","journal-title":"Eur J Hybrid Imaging."},{"key":"2026082708000589000_jnumed.125.271954v1.13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13550-020-00651-z","article-title":"Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET\/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumours","volume":"10","author":"Kim","year":"2020","journal-title":"EJNMMI Res."},{"key":"2026082708000589000_jnumed.125.271954v1.14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1159\/000530771","article-title":"Prognostic value of somatostatin receptor-derived volumetric parameters from a hybrid standardized uptake value thresholding method in patients with 68Ga-DOTATATE-avid stage IV neuroendocrine neoplasms: a preliminary study","volume":"114","author":"Cheng","year":"2024","journal-title":"Neuroendocrinology."},{"key":"2026082708000589000_jnumed.125.271954v1.15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MNM.0000000000001861","article-title":"Defining the optimal segmentation method for measuring somatostatin receptor expressing tumor volume on 68Ga-DOTATATE positron emission tomography\/computed tomography to predict prognosis in patients with gastroenteropancreatic neuroendocrine tumors","volume":"45","author":"Filizoglu","year":"2024","journal-title":"Nucl Med Commun."},{"key":"2026082708000589000_jnumed.125.271954v1.16","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1053\/j.gastro.2017.11.008","article-title":"Prognostic utility of total 68Ga-DOTATATE-avid tumor volume in patients with neuroendocrine tumors","volume":"154","author":"Tirosh","year":"2018","journal-title":"Gastroenterology."},{"key":"2026082708000589000_jnumed.125.271954v1.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262652"},{"key":"2026082708000589000_jnumed.125.271954v1.18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/metabo11020072","article-title":"Reproducibility of baseline tumour metabolic volume measurements in diffuse large B-Cell lymphoma: is there a superior method?","volume":"11","author":"Eude","year":"2021","journal-title":"Metabolites."},{"key":"2026082708000589000_jnumed.125.271954v1.19","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-022-05971-x","article-title":"The role of quantitative tumor burden based on [68Ga]Ga-DOTA-NOC PET\/CT in well-differentiated neuroendocrine tumors: beyond prognosis","volume":"50","author":"Chen","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082708000589000_jnumed.125.271954v1.20","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262782"},{"key":"2026082708000589000_jnumed.125.271954v1.21","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/s00259-019-04455-9","article-title":"Prognostic value of somatostatin receptor expressing tumor volume calculated from 68Ga-DOTATATE PET\/CT in patients with well-differentiated neuroendocrine tumors","volume":"46","author":"Toriihara","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2026082708000589000_jnumed.125.271954v1.22","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-013-0718-4"},{"key":"2026082708000589000_jnumed.125.271954v1.23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.acra.2020.08.028","article-title":"68Ga-DOTATATE PET\/CT: the optimum standardized uptake value (SUV) internal reference","volume":"29","author":"Ragab","year":"2022","journal-title":"Acad Radiol."},{"key":"2026082708000589000_jnumed.125.271954v1.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266346"},{"key":"2026082708000589000_jnumed.125.271954v1.25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cancers14040984","article-title":"[68Ga]DOTATOC PET\/CT radiomics to predict the response in GEP-NETs undergoing [177Lu]DOTATOC PRRT: the \u201ctheragnomics\u201d concept","volume":"14","author":"Laudicella","year":"2022","journal-title":"Cancers (Basel)."},{"key":"2026082708000589000_jnumed.125.271954v1.26","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.125.269688"},{"key":"2026082708000589000_jnumed.125.271954v1.27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-024-02451-4","article-title":"Evaluation of multiple-vendor AI autocontouring solutions","volume":"19","author":"Goddard","year":"2024","journal-title":"Radiat Oncol."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.125.271954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:00:22Z","timestamp":1787842822000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.125.271954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":27,"alternative-id":["10.2967\/jnumed.125.271954"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.125.271954","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]}}}